In addition, tamoxifen and raloxifene inhibited the growth of bladder cancer cells negative for ERα and positive for ERβ (determined via western blot) (19, 47, 67, 68) and xenograft tumors derived from these cells (68). The gene discussed is ESR2; the disease is urinary bladder carcinoma.